SV 2021
DOI: 10.22514/sv.2021.046
|View full text |Cite
|
Sign up to set email alerts
|

Effect of prehospital intraosseous combined with in-hospital intravenous access in out-of-hospital cardiac arrest

Abstract: Objective: Obtaining vascular access during out-of-hospital cardiac arrest (OHCA) is challenging. The aim of this study was to compare the effectiveness of prehospital intraosseous infusion (IO) combined with in-hospital intravenous (IV) (pre-IO + in-IV) access versus the simple IV (pre-IV + in-IV) access in adult OHCA patients who do not achieve prehospital return of spontaneous circulation (ROSC). Methods: This retrospective observational study included adults with OHCA of presumed cardiac etiology between … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 20 publications
(31 reference statements)
0
1
0
Order By: Relevance
“…Factors such as patient-specific variables, as well as the proficiency of the attending health professional, can contribute to complexities and delays in pharmacological intervention. [6] This is where intraosseous (IO) access, admired for its speedy placement, superior success rates when compared to IV cannulation, and relatively minimal procedural risk, has emerged as a preferred modality for drug administration during resuscitation. [7,8] The 2020 American Heart Association (AHA) Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care also back this modality, recommending IO access when attempts at IV access are unsuccessful or not feasible (COR 2b, LOE B-NR).…”
Section: Introductionmentioning
confidence: 99%
“…Factors such as patient-specific variables, as well as the proficiency of the attending health professional, can contribute to complexities and delays in pharmacological intervention. [6] This is where intraosseous (IO) access, admired for its speedy placement, superior success rates when compared to IV cannulation, and relatively minimal procedural risk, has emerged as a preferred modality for drug administration during resuscitation. [7,8] The 2020 American Heart Association (AHA) Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care also back this modality, recommending IO access when attempts at IV access are unsuccessful or not feasible (COR 2b, LOE B-NR).…”
Section: Introductionmentioning
confidence: 99%